2023 Midwest Radiation Oncology Symposium (Attendee Information)

Fred & Pamela Buffett Cancer Center – Rm 0.12.103 (NEW LOCATION!)
505 S 45th Street, Omaha, NE 68105

Parking

• Complimentary parking for campus visitors is available on the top level of Lot 50. Download map
• If you are an employee/student of UNMC/Nebraska Medicine, please park in your regularly assigned parking area.
• UNMC CCE is not liable for any parking ticket that a participant may incur when attending this symposium.

• The Zoom link for the live stream will be sent via email a few days prior to the symposium. If you do not see this email in your Inbox, please check your junk email folder. If you still do not see the message, please send an email to Brenda Ram.
• To join the symposium, sign in to Zoom using your first and last name.
• Once you are in the webinar, go to the chat box and type in your first and last name so your attendance may be recorded.

Read the UNMC CCE Disclosure Declaration Policy 

Disclosures

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.

FACULTY

The following have disclosed relevant financial relationships:

Christopher R. D'Angelo, MD

• Advisory Board: Bristol-Myers Squibb Company; Ono Pharmaceutical Co., Ltd.; Seagen Inc.
• Consultant: AbbVie, Inc.
• Researcher: AbbVie, Inc.; Beigene; Bristol-Myers Squibb Company; Fate Therapeutics

Megan Hyun, PhD, DABR*

• Researcher: Standard Imaging, Inc.
• Speaker: Radformation, Inc; Varian Medical Systems, Inc.

Sidharth Mahapatra, MD, PhD

• Grant Reviewer: American Institute of Biological Sciences; Cariplo Foundation, Italy; New Jersey Department of Health

• Research funding: Edna Ittner Pediatric Research Fund; FPBCC/PCRG Pilot Project Grant; Team Jack Foundation

• INVESTIGATIONAL/OFF-LABEL USE OF DRUGS DISCLOSURE:  Nortriptylline, Simvastatin, Fluoxetine, Sertraline for Anti-neoplastic effects in group 3 medulloblastoma

Jessica Maxwell, MD, MSc

• Advisor: Dilon Technologies, Inc.

Benjamin A. Teply, MD

• Advisory Board: Exelixis, Inc.; Lilly; Sanofi; Seagen Inc.
• Consultant: ONVIV/Cancer Expert Now
• INVESTIGATIONAL/OFF-LABEL USE OF DRUGS DISCLOSURE: Off-label drug discussion of Immunotherapy (Pembrolizumab/Nivolumab) in muscle-invasive bladder cancer

Chi (Kevin) Zhang, MD, PhD*

• Research Grant: AstraZeneca
• Travel Support: GT Medical Technologies, Inc.

The following have nothing to disclose:

• Omar K. M. Abughanimeh, MBBS
• Ellie Bacon, MS
• Michael Baine, MD, PhD
• Christopher M. Bingcang, MD
• Charles A. Enke, MD, FASTRO, FACR*
• Eric Ford, PhD, DABR, FAAPM, FASTRO
• Kyle J. Gallagher, PhD, DABR
• Samuel Hendley, PhD
• Miki Katzir, MD
• Mridula Krishnan, MBBS
• Sean Langenfield, MD, FACS, FASCRS
• Chi Lin, MD, PhD*
• Jeff M. Michalski, MD, MBA, FASTRO
• Kyuhak Oh, PhD
• Jared P. Schober, MD
• Diane Schott, PhD
• Andrew Wahl, MD
• Sarah Wisnoskie, MS
• Shannon L. Wong, MD
• Ying Yan, PhD
• Weining (Ken) Zhen, MD, FACR, FASTRO
• Su-min Zhou, PhD

 *Faculty and planning committee member

PLANNING COMMITTEE

The following have nothing to disclose:

• Heidi Keeler, PhD, MSN/MBA, RN
• Renee Paulin, MSN, RN, CWOCN
• Brenda Ram, CMP, CHCP
• Hongmei Ren, RN
• Charlene Rhodd, MS, CMD, RT (R)(T), CT 

• Courtney Smith
• Ann L. Yager, MHA, BS, RT, (R)(T)

The following materials (in PDF) are available for download until Sept. 8, 2023. No part of these materials may be reproduced without prior written permission.

Friday, Aug. 18

SESSION 1: GENITOURINARY CANCER

• Prostate Cancer Clinical Trials in the Radiation Therapy Oncology Group/NRG Oncology: A Paradigm for Clinical Research
  Jeff M. Michalski, MD, MBA, FASTRO
• Cystoscope and Adjuvant Testing to Determine Response to Neoadjuvant Chemotherapy to Identify Patients for Bladder Sparing Protocols for Muscle Invasive Bladder Cancer
  Jared P. Schober, MD
• Current and Emerging Systemic Therapy Paradigms with Bladder Chemoradiation
  Benjamin A. Teply, MD
• Local Treatment Options in Localized Invasive Bladder Cancer: Framing the Role of Radiation Therapy in the Context of Emerging Data
  Michael Baine, MD, PhD

SESSION 2: LYMPHOMA

• Sequencing of CAR-T Therapy for B-cell Lymphoma: Current and Future Landscape
  Christopher R. D'Angelo, MD

• CAR-T Therapy for B-cell Lymphoma: Does Radiation Therapy Have a Role?
  Charles A. Enke, MD, FASTRO, FACR

SESSION 3: HEAD AND NECK CANCER

• Transoral Laser Surgery for Early-Stage Larynx Cancer
  Christopher M. Bingcang, MD
• Laryngeal Preservation Therapy (LPT) for Locally Advanced-Stage Larynx Cancer
  Weining (Ken) Zhen, MD, FACR, FASTRO
• Systemic Therapy in Recurrent and Metastatic Head and Neck Cancer
  Omar K. M. Abughanimeh, MBBS

SESSION 4: CENTRAL NERVOUS SYSTEM CANCER

• Evidence-Based Applications of Proton Therapy for Brain Tumors
  Chi (Kevin) Zhang, MD, PhD
• Surgical Advancement in Thoracolumbar Tumors
  Miki Katzir, MD
• Deciphering Molecular Mechanisms Triggering Pediatric Group 3 Medulloblastomas
  Sidharth Mahapatra, MD, PhD

Saturday, Aug. 19

SESSION 5: MEDICAL PHYSICS AND ACCESS TO CARE

• Access to Quality Care in Oncology
  Eric Ford, PhD, DABR, FAAPM, FASTRO
• Offline Adaptive Prostate Radiotherapy in Rural Medicine and Other Low-Resource Settings
  Ellie Bacon, MS

SESSION 6: PHYSICS AND RADIOBIOLOGY OF FLASH

• Initial Experience with an Electron FLASH System
  Kyuhak Oh, PhD and Su-min Zhou, PhD
• Biological Effects of Ultra-High Dose Rate (FLASH) Radiation on Normal and Cancer Cells
  Ying Yan, PhD

SESSION 7: MEDICAL PHYSICS EDUCATION

• Global Health Rotation in Low- and Middle-Income Countries During Medical Physics Residency Training Program
  Samuel Hendley, PhD and Kyle J. Gallagher, PhD, DABR
• E-Learning Modules: Bringing Health Professions Educational Content to a Broader Audience
  Sarah Wisnoskie, MS, DABR

SESSION 8: BREAST CANCER

• Oncoplastic Considerations After Breast-Conserving Surgery
  Jessica Maxwell, MD, MSc
• Plastic Surgery Approaches After Mastectomy for Breast Cancer
  Shannon L. Wong, MD
• Cosmetic Outcomes Following Breast or Chest Wall Radiotherapy
  Andrew Wahl, MD

SESSION 9: GASTROINTESTINAL CANCER

• Immunotherapy in Colorectal Cancer - What, When, and How?
  Mridula Krishnan, MBBS
• When the Guidelines Can’t Keep Up: Evidence-Based Management of Rectal Cancer
  Sean Langenfeld, MD, FACS, FASCRS
• The Role of Short-Course and Long-Course Radiation Therapy in the Total Neoadjuvant Therapy for Locally Advanced Rectal Adenocarcinoma
  Chi Lin, MD, PhD